ZBTB7A and glioblastoma: As shown in Fig. 7a, b, there were significant differences in ZBTB7A expression in cancer tissues from GBM patients with different pathological grades, indicating a positive correlation between ZBTB7A expression and clinical pathological grading (Fig. 7a).